Central Medience Supply acquires two Osaka firms to expand in cardiovascular devices
What's the deal? Central Medience Supply, a Tokyo-based medical supply wholesaler and subsidiary of Central Medience Group, has acquired 100% of the shares in Osaka-based B-Side and its affiliate Live Through. The deal, announced on May 11, brings two companies specialising in cardiovascular medical device sales and academic conference management into the group.
B-Side and Live Through have built deep expertise in vascular treatments including PCI, EVT, and shunt PTA, earning trust from medical institutions across western Japan. The acquisition also gives Central Medience Supply its first foothold in academic conference operations — a new business line for the group.
Why now? Central Medience Supply has focused on wholesale distribution of medical materials and devices but had not yet entered the cardiovascular segment. Acquiring B-Side, founded in 2010, lets it leapfrog into a high-value speciality rather than building capabilities from scratch.
The deal also addresses a geographic gap. Central Medience Supply is headquartered in Tokyo; B-Side's established sales network in the Kansai region — centred on Osaka — gives the group a ready-made western Japan presence.
What could go wrong? Integrating niche medical device expertise with a broad-based wholesaler is never straightforward. Cardiovascular products demand specialist knowledge and close relationships with clinicians — the kind of intangible assets that can erode during ownership transitions.
The conference management business, while an interesting diversifier, is also a departure from core supply-chain operations. Stretching into unfamiliar territory could dilute management focus.
The signal: Japan's medical supply sector is consolidating as distributors seek scale, broader product portfolios, and regional coverage. Deals like this reflect a wider trend of wholesalers moving beyond pure logistics into value-added services — conference support, clinical education, and specialised device consulting — to differentiate themselves in a market squeezed by pricing pressure and hospital procurement reforms.
For the Kansai healthcare ecosystem, the acquisition signals growing competition among Tokyo-based groups looking to plant flags in western Japan's large hospital market.
Read more: prtimes.jp
